Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial

Table 2 Flowchart of assessment

			Treatment
Visit (week)	Screening	Randomization	2	4	8	16	28	40	46
Valid informed consent gained	√	√
Full demographic details	√
Relevant medical history taken	√	√
Concomitant medications	√	√	√	√	√	√	√
Anthropometric measurements		√
Blood pressure measurement	√	√	√	√	√	√	√	√	√
Pulse wave velocity and pulse waveform analysis measurement		√						√	√
Haematological and full biochemical profile	√		√					√	√
Renal profile				√	√	√	√
Urine albumin:creatinine ratio	√							√	√
EQ5D-5 L questionnaire		√						√
Medication monitoring questionnaire		√	√	√	√	√	√	√	√

ISSN: 1745-6215